AC-201

N/A

Report date: 2025/03/31 10:53:20
NME

Base Information

Drug NameAC-201
Drug Alias NameAC-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitorsTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase 2Tyrosine-protein kinase JAK1
Therapy Area/IndicationsPlaque psoriasisPsoriasisLupus Erythematosus, Systemic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAccro Bioscience (Suzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdAccro Bioscience (Suzhou) Co LtdShanghai Fosun Pharmaceutical Industrial Development Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasisLupus Erythematosus, Systemic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A